BridgeBio Pharma Reports Inducement Grants Under Nasdaq Listing Rule
BridgeBio Pharma reported inducement grants under Nasdaq Listing Rule 5635(c)(4).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
4 results loaded, newest first. End of these results.
BridgeBio reports inducement grants under Nasdaq Rule 5635(c)(4)
BridgeBio says its compensation committee approved inducement grants on Sept. 18, 2026 under Nasdaq Listing Rule 5635(c)(4).
BBIO - BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BBIO - BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BBIO Reports Inducement Grants
BBIO reports inducement grants under Nasdaq Listing Rule 5635(c)(4)